Quantitative Structure-Activity Relationship of Flavonoid Analogues. 3. Inhibition of p56lck Protein Tyrosine Kinase

Journal of Chemical Information and Computer Sciences

Volumn 40, Issue 4, 2000, Pages 994-1001

  Oblak, M ^a   Randic, M ^a,b   Solmajer, T ^a,c  

^a NATIONAL INSTITUTE OF CHEMISTRY   (Slovenia)

^b Lek dd   (Slovenia)

^c DRAKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; FLAVONOID; PROTEIN KINASE LCK;

ARTICLE; CHEMISTRY; COMPUTER PROGRAM; DRUG ANTAGONISM; ELECTRICITY; HUMAN; QUANTUM THEORY; REGRESSION ANALYSIS; STRUCTURE ACTIVITY RELATION;

ELECTROSTATICS; ENZYME INHIBITORS; FLAVONOIDS; HUMANS; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); QUANTUM THEORY; REGRESSION ANALYSIS; SOFTWARE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034222395     PISSN: 00952338     EISSN: None     Source Type: Journal    
DOI: 10.1021/ci000001a     Document Type: Article

References (28)

1. Hanks, S. K.; Quinn, A. M.; Hunter, T. The Protein Kinase Family: Conserved Features and Deduced Phylogeny of the Catalytic Domains. Science 1988, 241, 42-52.
2. Hunter, T. Protein Modification: Phosphorylation on Tyrosine Residues. Curr. Opin. Cell Biol. 1989, 1, 1168-1181.
3. Ullrich, A.; Schlessinger, J. Signal Transduction by Receptors with Tyrosine Kinase Activity. Cell 1990, 61, 203-212.
4. Bishop, J. M. The Molecular Genetics of Cancer. Science 1987, 235, 305-311.
5. Levitzki, A.; Gazit, A. Tyrosine Kinase Inhibition: An Approach to Drug Development. Science 1995, 267, 1782-1788.
6. Burke, R. T. Protein-Tyrosine Kinase Inhibitors. Drugs Future 1992, 17, 119-131.
7. Chang, C.; Geahlen, L. R. Protein-Tyrosine Kinase Inhibition: Mechanism-Based Discovery of Antitumor Agents. J. Nat. Prod. 1992, 55, 1529-1560.
8. Groundwater, P. W.; Solomons, H. R. K.; Drewe, A. J.; Munawar, A. M. Protein Tyrosine Kinase Inhibitors. Prog. Med. Chem. 1996, 33, 323-329.
9. Geahlen, L. R.; McLaughlin, J. L. Piceatannol (3,4,3′,5′-tetrahydroxy-trans-stilbene) is a naturally occurring protein-tyrosine kinase inhibitor. Biochem. Biophys. Res. Commun. 1989, 165, 241-245.
10. Geahlen, L. R.; Koonchanok, M. N.; McLaughlin, J. L.; Patt, D. E. Inhibition of protein-tyrosine kinase activity by flavonoids and related compounds. J. Nat. Prod. 1989, 52, 982-986.
11. Cushman, M.; Nagarathnam, D.; Geahlen, L. R. Synthesis and Evaluation of Hydroxylated Flavones and Related Compounds as Potential Inhibitors of Protein Tyrosine Kinase p56. J. Nat. Prod. 1991, 54, 1345-1352.
12. Cushman, M.; Nagarathnam, D.; Burg, L. D.; Geahlen, L. R. Synthesis and Protein-Tyrosine Kinase Inhibitory Activities of Flavonoid Analogues. J. Med. Chem. 1991, 34, 798-806.
13. Cushman, M.; Zhu, H.; Geahlen, L. R.; Kraker, J. A. Synthesis and Biochemical Evaluation of a Series of Aminoflavones as Potential Inhibitors of Tyrosine Protein Kinases and Serine/Threonine Protein Kinases p56, EGFr, p60. J. Med. Chem. 1994, 37, 3353-3362.
14. Hagiwara, M.; Inoue, S.; Tanaka, T.; Nunoki, K.; Ito, M.; Hidaka, H. Differential Effects of Flavonoids as Inhibitors of Tyrosine Protein Kinases and Serine/Threonine Protein Kinases. Biochem. Pharmacol. 1988, 37, 2987-2992.
15. Akiyama, T.; Ishida, J.; Nakagawa, S.; Ogawara, H.; Watanabe, S.; Itoh, N.; Shibuya, M.; Fukami, Y. Genistein, a Specific Inhibitor of Tyrosine-Specific Protein Kinases. J. Biol. Chem. 1987, 262, 5592-5595.
16. lck Protein Tyrosine Kinase: A Classical/Quantum Chemical Approach. Quant. Struct.-Act. Relat. 1998, 17, 7-13.
17. lck Protein Tyrosine Kinase: A Neural Network Approach. J. Chem. Int. Comput Sci. 1997, 37, 990-998.
18. Amic, D.; Davidovic-Amic, D.; Juric, A.; Lucic, B.; Trinajstic, N. Structure-Activity Correlation of Flavone Derivatives for Inhibition of cAMP Phosphodiesterase. J. Chem. Inf. Comput Sci. 1995, 35, 1034-1038.
19. Costantino, L.; Rastelli, G.; Albasini, A. A rational approach to the design of flavones as xanthine oxidase inhibitors. Eur. J. Med. Chem. 1996, 31, 693-699.
20. Koga, Y.; Kimura, N.; Minowada, J.; Mak, W. T. Expression of the Human T-Cell-Specific Tyrosine Kinase YT16(lck) Message in Leukemic T-Cell Lines. Cancer Res. 1988, 48, 856-859.
21. Abraham, N.; Levin, D. S.; Marth, D. J.; Forbush, A. K.; Perlmutter, M. R. Thymic tumorigenesis induced by overexpression of p56. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 3977-3981.
22. Spartan User's Guide, Version 4.0; Wavefunction, Inc.: Irvine, CA. 1995.
23. Katritzky, A. R.; Lobanov, V. S.; Karelson, M. CODESSA, Reference Manual, 1994.
24. Karelson, M.; Lobanov, V. S.; Katritzky, A. R. Quantum-Chemical Descriptors in QSAR/QSPR Studies. Chem. Rev. 1996, 96, 1027-1043.
25. Randic, M. Resolution of Ambiguities in Structure-Property Studies by Use of Orthogonal Descriptors. J. Chem. Inf. Comput. Sci. 1991, 31, 311-320.
26. Amic, D.; Davidovic-Amic, D.; Beslo, D.; Lucic, B.; Trinajstic N. J. Chem. Inf. Comput. Sci. 1997, 37, 581-586.
27. Lucic, B.; Nikolic, S.; Trinajstic, N.; Juretic, D. J. Chem. Inf. Comput. Sci. 1995, 35, 532-538.
28. Lucic, B.; Trinajstic, N.; Sild, S.; Karelson, M.; Katritzky, A. R. J. Chem. Inf. Comput. Sci. 1999, 39, 610-621.